Various cell types in the TME of cancers release IL-6, leading to the activation of the IL-6/JAK/STAT3 pathway in both tumour cells and tumour-associated immune cells, which in turn promotes tumour cell proliferation, invasiveness and metastasis [137]. This evidence concerns the gene STAT3 and neoplasm.